William Hoffman, Director at Inari Medical, Inc. (NARI), sold 45,500 shares at $64.40 ($2.9M) on 2023-04-17, disclosed to the SEC on 2023-04-19.
Scheduled sale ($2.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.40 | 5,500 | $354K | 12.0% |
| 2 | $64.40 | 5,500 | $354K | 12.0% |
| 3 | $64.42 | 8,908 | $574K | 19.5% |
| 4 | $64.42 | 8,908 | $574K | 19.5% |
| 5 | $65.02 | 4,500 | $293K | 9.9% |
| 6 | $65.04 | 6,092 |
| $396K |
| 13.5% |
| 7 | $65.04 | 6,092 | $396K | 13.5% |
| Total | $64.64 avg | 45,500 | $2.9M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |